pharma 1 3

Tag: "pharma" at medical news

Panacea To Market Measles Vaccine In India

Homegrown pharma major Panacea Biotec today said it is working on four vaccines, including those for treating anthrax and Japanese encephalitis. // "We are currently working on four vaccines for anthrax, dengue, Japanese encephalitis and hepatitis-A. Phase I and II...

Orchid Gets USFDA Nod for Cephalexin

...d Chemicals' distribution alliance with US generic pharma major Par Pharmaceuticals Inc, it informed the Bombay Stock Exchange. Orchid added that its Cephalexin capsules are already marketed in the US through partnership with Par Pharmaceuticals and following this approval, the number of dosage forms, oral...

OPPI Opposes Draft National Pharmaceuticals Policy

...l sector // and lead to the destruction of Indian pharma companies. "The previous governments had reduced the number of drugs under control from 347 to 143 and finally to 74. The Drug Policy in February 2002 had proposed a further reduction from 74 to about 30. The current policy hence will not promote th...

Expanding Price Control Detrimental for Pharma Companies: CII

...ell as the economy. "Healthy competition between pharma companies already ensures reasonable pricing. Instead of affecting the growth by over regulation, it would be better to allow market forces to determine prices," CII's National Committee on Drugs and Pharmaceuticals Chairman Ajay Piramal told reporte...

Ranbaxy Acquires Glaxosmithkline's Generic Unit in Spain

...sence and product portfolio in the Spanish market, pharma major Ranbaxy Laboratories Ltd today said it has acquired GlaxoSmithKline's Mundogen generic business in Spain. // Ranbaxy's CEO and MD Malvinder Mohan Singh said that the acquisition was in line with the company's M&A strategy to focus on the EU m...

Cabinet Clears Purchase Preference Policy for Pharma PSUs

...omous bodies will give first preference to central pharma PSUs like IDPL// and their subsidiaries for purcha..., the first preference will also be given to these pharma PSUs and their subsidiaries by state governments in their purchases which are funded by the Centre. ...

Viread To Retail In India For $1

...red into generic licensing deals with three Indian pharma majors - Emcure Pharmaceuticals, Hetero Drugs and ...red with generic versions currently available from pharma major Cipla, priced at over $1,200 per year, the new pricing is bound to come as a relief. Viread ...

Dutch Pharma Firm to Invest $500 mn in India

DSM Anti-Infectives, a $20 billion pharma firm based in the Netherlands, Wednesday said it would invest $500 million in India and hoped to capture a 10 percent share of the// country's antibiotics market. "We are continuously exploring opportunities to invest in India. Currently, our sales...

Ranbaxy Launches Asthma Inhalation Capsule in India

...t for the Indian market with the Netherlands-based pharma company, Eurodrug Laboratories, for the asthma product Doxophylline - a novel Xanthine bronchodilator, sold under the brand name 'Synasma'. Source-IANS...

Impact of New Drug Retail Prices Soon: Paswan

... Vilas Paswan said Tuesday. "The agreement by the pharma industry to reduce the retail margin for generic a...l be felt in a month as we have agreed to give the pharma industry time till Nov 2 to phase out the current stocks with old minimum retail price (MRP) in reta...

India's Wockhardt Acquires Irish Firm

India's pharma and biotech major Wockhardt Limited announced on Tuesday the acquisition of Pinewood Laboratories// Limited of Ireland for $150 million that will help it broaden its presence in the European market. 'This acquisition gives us a larger footprint in ...

Ranbaxy To Market Pain Killer In Canada

...Inc. (RPCI), the wholly owned subsidiary of Indian pharma major Ranbaxy Laboratories Limited (RLL), has entered// into a tie-up with Janssen-Ortho Inc. (JOI) for marketing of its generic painkiller Fentanyl in Canada. The second product to be commercialised by RPCI, Fentanyl would be sold under Ranbaxy's l...

Free Medicines, Health Insurance for Poor Soon: Paswan

...ffort by small and medium-sized enterprises in the pharma industry, which has a turnover over Rs.90 billion. "We are also studying the launching of a health insurance programme soon for below the poverty line (BPL) families," said Paswan. Free medication and health insurance cover for the BPL (below pov...

Ranbaxy to Market Debiopharm's New Drug in India

Indian pharma major Ranbaxy Laboratories Limited has signed an exclusive licensing agreement with Swiss biopharmaceutical development company Debiopharm Group to// market its new gastro-enterology drug. Debiopharm's new drug Sanvar, an injectable molecule, is fo...

Hindustan Latex To Market Vaccines

...rnataka), which is currently manufacturing women's pharma products including contraceptives," a company official told IANS. With communicable diseases accounting for a large share of health problems in India, especially among the poor, HLL plans to use its wide network in India and overseas to make vaccine...

Tax Concession to Pharma Comapnies

...urred is allowed to encourage investment in R&D in pharma sector. Besides this, Income Tax Act also contains the provision of Section 80-IB (8A) under which for any company carrying on Scientific R&D, deduction of 100 per cent of profit and gains of such business for a period of 10 consecutive assessment ye...

Dr. Reddy's To Launch 'Polypill' For Treating Heart Disease

Indian pharma major Dr. Reddy's Laboratories will launch a first-of-its-kind pill to tackle heart diseases in the second half of 2007, it was announced Thursday. // The company has teamed up with researchers at University of Auckland, New Zealand, for trials of ...

Dr. Reddy's To Invest $100 Mn In Andhra

Indian pharma major Dr. Reddy's Laboratories (DRL) is all set to invest nearly Rs. 4.5 billion ($100 million) as part of their expansion drive in Andhra Pradesh, the company's home state. // 'As part of our plan, $100 million will be invested within the next 18 m...

A Combined Heart Pill-developed by Dr. Reddy’

Dr. Reddy’s, the Indian pharma giant has decided to join hands with the University of Auckland, //New Zealand to begin Global trials of a new fixed dose combination or “polypills” to prevent strokes and heart attacks. The polypill will combine four drugs- aspirin, statin(to reduc...

Indian American Scientist at Work on Multi-targeted Drug

...ustry, the Indo-American Chamber of Commerce and a pharma industry lobby. In India to address industry bodies during a five-city tour on his vision of India as a knowledge hub, Chakrabarty urged the industry leaders to help nurture innovation. Expressing keenness to bring his candidate drug to the mark...

1 2 3 4 5